During the past decade, Univ of Tennessee / Div of Infect Dis / Dept of Med conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Univ of Tennessee / Div of Infect Dis / Dept of Med" are "HIV Infections" (2 trials). Many other conditions were trialed in "Univ of Tennessee / Div of Infect Dis / Dept of Med" in a lesser frequency.

Most popular intervention types in "Univ of Tennessee / Div of Infect Dis / Dept of Med" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abacavir sulfate" (1 trials), "Delavirdine mesylate" (1 trials), "Indinavir sulfate" (1 trials), "Lamivudine/Zidovudine" (1 trials) and "Zidovudine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Univ of Tennessee / Div of Infect Dis / Dept of Med" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Univ of Tennessee / Div of Infect Dis / Dept of Med". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Univ of Tennessee / Div of Infect Dis / Dept of Med, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Univ of Tennessee / Div of Infect Dis / Dept of Med, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".